Vol 27 Number 5, May 2018

In this issue

In this month’s Journal of Wound Care (JWC): can 3D-printing be used to aid wound healing? ‘Clinical application of a 3D-printed scaffold in chronic wound treatment: a case series’ describes the results of this exciting new treatment with 3D-printed scaffolds or 3D-printing powder mixed with platelet-rich fibrinogen in five patients. Following on from ‘Delayed referral of patients with diabetic foot ulcers across Europe: patterns between primary care and specialised units’ in the May issue of JWC, the same author group assesses the perception of diabetic foot ulcers (DFUs) among general practitioners. The study, in four European countries, is based on 600 questionnaires and 1188 patient cases of DFU management.

Pain control and reduction is an important part of wound management. ‘Microcurrent as an adjunct therapy to accelerate chronic wound healing and reduce patient pain’ reports the results of a 100-patient study, where the patients were loaned a home-microcurrent device to treat their chronic wounds three times a day for four weeks. Other practice articles this month include a case of a rare Mycobacterium avium complex-infected wound and a 22-patient study looking at sub-epidermal moisture (SEM) to assess early skin damage, before it is visible to the naked eye.

In the research section, there are two articles: the first examines the effect of high-dose vitamin C and mesenchymal stem cells in a mouse model of wound healing, the second uses in vitro methods to look at the antimicrobial activity of a series of commercially available dressings.

Also this month, John Stephenson explains statistics, in the second of four editorials this year, ‘How to interpret a p-value’ and Professor William Jeffcoate examines the conflict over the need for evidence when choosing a wound dressing.


There has been a great deal of debate around diabetic foot ulcers (DFUs) and pressure ulcers (PUs) on the feet of patients with diabetes, in terms of how to define, detect, assess and treat them. The confusion and lack of evidence in differentiating between these two types of foot ulcers, particularly on the heel, can lead to misdiagnosis, which can increase both financial and patient-related costs.

To address and tackle those inconsistencies, the Journal of Wound Care has published its first international consensus document, 'Identifying and treating foot ulcers in patients with diabetes: saving feet, legs and lives'.

See our subscription options

Never miss an issue

Be the first to find out what is each new issue by signing up to our newsletter.